Loading...

NeuroScientific Biopharmaceuticals Limited

NSB.AX•ASX
Healthcare
Biotechnology
A$0.17
A$-0.01(-2.94%)

NeuroScientific Biopharmaceuticals Limited (NSB.AX) Company Profile & Overview

Explore NeuroScientific Biopharmaceuticals Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

NeuroScientific Biopharmaceuticals Limited (NSB.AX) Company Profile & Overview

NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. The company was incorporated in 2002 and is based in Cottesloe, Australia.

SectorHealthcare
IndustryBiotechnology
CEOAnthony James Keating

Contact Information

https://www.neuroscientific.com
61 8 6382 1805
85 Forrest Street, Cottesloe, WA, 6011

Company Facts

IPO DateJul 27, 2018
CountryAU
Actively Trading

Frequently Asked Questions

;